RxDoctor Payments Data

Francis Shannon, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Royal Oak, MINPI 1023085578

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (42.8%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Medtronic at 52.7% of the total. Reporting peaked in 2019 at $11,487 and has fallen 97.9% since, to $247 in 2023.

$21,563in general payments, 2019–2025

Across 78 payments — averaging $276.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$11K
  • Boston Scientific$8K
  • Abbott$1K
  • Atricure, Inc.$395
  • Abiomed$138
  • Angiodynamics, Inc.$122
  • plus $371 from 8 others
$7,375in research payments, 2019–2025

Across 8 payments — averaging $921.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$7K

What the payments were for

  • Consulting fees$7,80036%
  • Speaking & faculty fees$1,6248%
  • Travel & lodging$9,22443%
  • Food & beverage$2,91514%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)43$11,370
Boston Scientific2$7,972
Abbott11$1,196
Atricure, Inc.6$395
Abiomed2$138
Angiodynamics, Inc.1$122
Edwards Lifesciences2$114
Getinge USA Sales, LLC4$74
Artivion, Inc.1$52
Johnson & Johnson2$49
Hemosonics LLC1$29
Terumo Cardiovascular Systems Corporation1$21
Pinnacle, Inc1$17
Zimmer Biomet1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,563 in reported general payments places this provider in the 80th percentile of 182 thoracic surgery (cardiothoracic vascular surgery) providers in Michigan.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Michigan

Medicare billing

Part B allowed, 2024
$23,351
Medicare patients
39
Services billed
52

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin11$44

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Royal Oak

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →